Long-term Use of Continuous Subcutaneous Hydrocortisone Infusion Therapy in Patients with Congenital Adrenal Hyperplasia

BACKGROUND: In a phase 2 short-term (6 months) study of patients with congenital adrenal hyperplasia (CAH), continuous subcutaneous hydrocortisone infusion (CSHI) was found to be a safe, effective, and well-tolerated method of replacing cortisol with improved disease and patient related outcomes. OB...

Full description

Saved in:
Bibliographic Details
Published in:Clin Endocrinol (Oxf)
Main Authors: Mallappa, Ashwini, Nella, Aikaterini A., Sinaii, Ninet, Rao, Hamsini, Gounden, Verena, Perritt, Ashley F., Kumar, Parag, Ling, Alexander, Liu, Chia-Ying., Soldin, Steven J., Merke, Deborah P.
Format: Artigo
Language:Inglês
Published: 2018
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC6166869/
https://ncbi.nlm.nih.gov/pubmed/30003563
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/cen.13813
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items